Paul Tudor Jones II started to build up the position in Dermata Therapeutics in Q4 2021. Since then they sold 637 shares. The investor sold all their shares in Q1 2023 and doesn't own any shares in Dermata Therapeutics anymore.
Avg closing price
Price range
Sold -637 shares
Q1 2023
Avg closing price
$58.34
Price range
$18.75
-
$79.20
New holding (+637 shares)
Q4 2021
Avg closing price
$884.13
Price range
$374.40
-
$1,500.00
News about Dermata Therapeutics Inc and Paul Tudor Jones II